Corby Spirit and Wine Limited reported its fiscal 2025 first quarter results for the period ended September 30, 2024 and announced dividend of $0.22 per share

TORONTO, Nov. 13, 2024 /CNW/ – Corby Spirit and Wine Limited (“Corby” or the “Company”) CSW CSW, a leading Canadian manufacturer, marketer and importer of spirits, wines and ready-to-drink cocktails (“RTDs”), today announced its financial results for the fiscal first quarter (“Q1”) period ended September 30, 2024. 

Corby delivered a solid Q1 with accretive contribution of the newly acquired RTD businesses (ABG and Nude) and ongoing market share gains in spirits, despite a volatile market environment.

Revenue at $65.1 million (+11% year-over-year), organic Revenue +3% (excluding Nude)

Adjusted Earnings from Operations1 at $15.6 million (+9%) in Q1
Reported Earnings from Operations at $15.0 million (+31%) in Q1

Adjusted Net Earnings1 at $10.2 million (+7%) in Q1
Reported Net Earnings at $9.3 million (+24%) in Q1

Quarterly Dividend declared of $0.22 per share

FINANCIAL RESULTS

Q1 FY25 results: Revenue for the first quarter of fiscal 2025 was $65.1 million, reflecting strong growth of +$6.5 million / +11% compared to the same period last year, with the inclusion of the Nude brand contributing revenue of $4.9 million in the period (acquired during the fourth quarter of fiscal 2024). Organic revenue1, which excludes the contribution from this acquisition, was $60.2 million during the quarter, reflecting resilient growth of +3% versus the prior year period with the following drivers:

  • Domestic case goods revenue of $48.4 million, +2% benefitting from the pipeline fill supporting the route-to-market modernization in Ontario and despite a negative impact from the LCBO labour strike during which its retail locations were closed for 17 days in July 2024;
  • Commissions of $7.7 million, with growth of +17%, reflecting pre-ordering by customers ahead of the holiday seasons, combined with the lapping of destocking patterns at liquor boards during the same period last year;
  • Export case goods sales of $3.2 million, a decline of -16%, reflecting the lapping of pipeline fills in new markets during the same period last year, partially offset by recovering shipments in the US from the normalization of inventory levels.

Marketing, sales and administration expenses increased $1.1 million, or +7% in the first quarter of fiscal 2025, primarily reflecting the inclusion of marketing expenses and overhead related to the Nude brands. Corby continued to invest purposefully in its strategic brands (including J.P. Wiser’s, Polar Ice and the RTD portfolio), while diligently managing overheads, with overall expenses increasing at a slower rate than revenue.

Corby delivered strong improvements in earnings and profitability in the first quarter of fiscal 2025, reflective of the double-digit revenue growth and expense management noted above. Reported earnings from operations of $15.0 million and adjusted earnings from operations1 of $15.6 million increased +31% and +9% respectively, versus the same period last year. The reported earnings include $0.6 million of costs related to Nude inventory adjusted to its fair value in the first quarter of fiscal 2025 and $2.8 million of costs related to ABG inventory adjusted to its fair value in the first quarter of fiscal 2024. Despite increased interest charges on a year-over-year basis related to the non-controlling interest obligation and the loan contracted to acquire ABG, Corby delivered reported net earnings of $9.3 million and adjusted net earnings1 of $10.2 million in Q1 FY25, increasing by +24% and +7% year-over-year, respectively.

The Company generated solid cash flow during the quarter, with Cash Flow from Operating Activities of $3.7 million, an increase of $8.5 million year-over-year. Corby exited Q1 FY25 with a healthy balance sheet and significant financial flexibility, with its Net Debt / Adjusted EBITDA1 ratio (on a rolling 12-month basis) at 1.8x at quarter-end.

Corby’s President and Chief Executive Officer, Nicolas Krantz, stated,

“I am pleased to share our results for the first quarter of fiscal 2025, which highlight a good start to the year for Corby, despite an overall beverage alcohol market that was severely impacted by the LCBO labour strike. We once again outperformed the broader spirits market in value growth during the quarter, supported by the diversity of our product portfolio, the ongoing effectiveness of our portfolio prioritization strategy, and Corby’s excellence in sales execution. In addition, the recent RTD acquisitions we have made have positioned Corby to capitalize on the new opportunities presented from consumer demand shifts and the recent route to market modernization in Ontario. Our Q1 revenue also reflected destocking patterns at liquor boards last year and pre-ordering ahead of the holiday season this year, which is expected to normalize throughout the fiscal year. Looking ahead, our ambition remains to deliver sustainable growth and protect profitability levels, while continuing to generate incremental long-term sustainable value for our shareholders.”

For further details, please refer to Corby’s Management’s Discussion and Analysis and interim condensed consolidated financial statements and accompanying notes for the three-month period ended September 30, 2024, prepared in accordance with International Financial Reporting Standards, available on www.sedarplus.ca and www.corby.ca/investors.

MARKET TRENDS

The LCBO labour strike in July 2024 significantly impacted the overall spirits market in value during this quarter, leading to a -1.5% decline in the last rolling 12 months. The RTD category was also impacted by the strike during the quarter but remained one of the fastest growing categories overall in the last twelve months at +4.6%.

Corby has outperformed the Canadian spirits market in value for more than two years, gaining share in most categories over this timeframe. Combining spirits, wines and RTDs, Corby outpaced the total beverage market in value growth by 150 basis points over the last 12 months, reflecting our ability to navigate the strike and the strength of our diversified product portfolio along with successful new product launches.

QUARTERLY DIVIDEND

The Corby Board of Directors is pleased to declare a dividend of $0.22 per Voting Class A Common Share and Non-Voting Class B Common Share of the Company, consistent with the amount of the last dividend payment. This dividend is payable on December 18, 2024 to shareholders of record as at the close of business on November 29, 2024.

QUARTERLY CONFERENCE CALL

Corby management will host a conference call on Thursday, November 14th, 2024, at 9:00 a.m. (EST) to review and discuss the financial and operational results for the Q1 period. Corby welcomes shareholders, investors, and others to access the conference call by dialing 437-900-0527 or toll free 1-888-510-2154 before the start of the call, or by joining via webcast at https://app.webinar.net/8RQ0Bnqg6zj. Following the conclusion of the call, a playback of the conference call will be available for 30 days by calling 289-819-1450 or 1-888-660-6345 and entering passcode 82600 #.

1)  NON-IFRS FINANCIAL MEASURES & RATIOS

In addition to using financial measures prescribed under IFRS, references are made in this news release to “Adjusted Earnings from Operations”, “Adjusted Net Earnings”, “Adjusted Basic Earnings per Share”, “Adjusted Diluted Earnings per Share”, “Organic Revenue” and “Adjusted EBITDA” which are non-IFRS financial measures. Non-IFRS financial measures and ratios do not have any standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other issuers.

Management believes the non-IFRS measures included in this news release are important supplemental measures of operating performance and highlight trends in the core business that may not otherwise be apparent when relying solely on IFRS financial measures.

Management believes that these measures allow for assessment of the Company’s operating performance and financial condition on a basis that is more consistent and comparable between reporting periods.

Adjusted Earnings from Operations is equal to earnings from operations before interest and taxes for the period adjusted to remove the costs incurred for business combination inventory fair value adjustments.

Adjusted Net Earnings is equal to net earnings for the period adjusted to remove the costs incurred for business combination inventory fair value adjustments and the notional interest charges related to NCI obligation, net of tax calculated using the effective tax rate.

Adjusted Basic Net Earnings Per Share is computed in the same way as basic net earnings per share and diluted net earnings per share, respectively, using the aforementioned Adjusted Net Earnings non-IFRS financial measure in place of reported Net Earnings.

Adjusted Diluted Earnings Per Share is computed in the same way as basic net earnings per share and diluted net earnings per share, respectively, using the aforementioned Adjusted Net Earnings non-IFRS financial measure in place of reported Net Earnings.

The following table presents a reconciliation of Adjusted Earnings from Operations and Adjusted Net Earnings to their most directly comparable financial measures for the three-month period ended September 30, 2024, and 2023:


Three months ended


Sep. 30,

Sep. 30,



(in millions of Canadian dollars)

2024

2023

 $ Change 

% Change






Earnings from operations

$                15.0

11.4

$             3.6

31 %

Adjustments:





Fair value adjustment to inventory1

0.6

2.8

(2.2)

(79 %)

Adjusted Earnings from operations

$                15.6

14.3

$             1.3

9 %






Net earnings

$                  9.3

7.5

$             1.8

24 %

Adjustments:





Fair value adjustment to inventory1

0.4

2.1

(1.7)

(79 %)

NCI Obligation2

0.5

0.5

n/a

Adjusted Net earnings

$                10.2

9.6

$             0.6

7 %






(1) Costs related to fair value adjustments to inventory due to business combination




(2) Notional interest costs related to non controlling interest obligations for ABG




 


Three months ended


Sep. 30,

Sep. 30,



(in Canadian dollars)

2024

2023

 $ Change 

% Change






Per common share





 – Basic net earnings

$                0.33

0.26

$           0.06

24 %

– Diluted net earnings

$                0.33

0.26

$           0.06

24 %






Basic Net earnings per share

$                0.33

0.26

$           0.06

24 %

Adjustments:





Fair value adjustment to inventory1

0.02

0.07

(0.06)

(79 %)

NCI Obligation2

0.02

0.02

n/a

Adjusted Basic Net earnings per share

$                0.36

0.33

$           0.02

7 %






Dilluted Net earnings per share

$                0.33

0.26

$           0.06

24 %

Adjustments:





Fair value adjustment to inventory1

0.02

0.07

(0.06)

(79 %)

NCI Obligation2

0.02

0.02

n/a

Adjusted Net Earnings per share

$                0.36

0.33

$           0.02

7 %






(1) Costs related to fair value adjustments to inventory due to business combination




(2) Notional interest costs related to non controlling interest obligations for ABG




Organic revenue growth is measured as the difference between revenue excluding case goods revenue from acquired or disposed entities compared to revenue in the preceding fiscal period during which the acquisition or disposal had not yet occurred.

The following table presents a reconciliation of total organic revenue and organic case goods revenue to their most directly comparable financial measures for the three-month period ended September 30, 2024, and 2023:


Three Months Ended


Sep. 30

Sep. 30



(in millions of Canadian dollars)

2024

2023

 $ Change 

 % Change 






Domestic case goods revenue

$          53.3

47.4

$            5.9

13 %

Adjusted for revenue from acquired or disposed entities

(4.9)

(4.9)

n.a.

Organic domestic case goods revenue

$          48.4

47.4

1.0

2 %

Export case goods revenue

3.2

3.8

(0.6)

(16 %)

Total commissions

7.7

6.5

1.1

17 %

Other services

0.9

0.9

0.0

3 %

Total organic revenue

$          60.2

58.6

$            1.5

3 %

Net Debt refers to the cash and deposits in cash management pools of the Company, less bank indebtedness and credit facilities payable and long-term debt.

The following table presents a reconciliation of total debt and net debt to their most directly comparable financial measures for the three-month periods ended September 30, 2024 and 2023:


Sep. 30,

Sep. 30,

(in millions of Canadian dollars)

2024

2023




Bank indebtedness

$                     –

$                 (3.9)

Credit facilities payable

(7.5)

(7.8)

Lease liabilities

(3.0)

(3.8)

Long-term debt

(114.0)

(98.5)

Total debt

$             (124.5)

$             (114.0)




Cash

$                  1.0

$                      –

Deposits in cash management pools

11.4

1.8




Bank indebtedness

(3.9)

Credit facilities payable

(7.5)

(7.8)

Long-term debt

(114.0)

(98.5)

Net debt

$             (109.1)

$             (108.4)

Adjusted EBITDA refers to Adjusted Earnings from Operations adjusted to remove amortization and depreciation disclosed in Corby’s financial statements. The following table presents a reconciliation of adjusted EBITDA to their most directly comparable quarterly financial measures from the three-month period ended September 30, 2024 to the three-month period ended September 30, 2022:


Three Months Ended


Sep 30,

Jun 30,

Mar 31,

Dec 31,

Sep 30,

Jun 30,

Mar 31,

Dec 31,

Sep 30,

(in millions of Canadian dollars)

2024

2024

2024

2023

2023

2023

2023

2022

2022











Adjusted Earnings from operations

$      15.6

9.2

9.2

12.0

$      14.3

5.9

4.8

11.2

10.5

Adjusted for depreciation & amortization

3.9

4.1

3.8

3.7

3.9

3.8

3.7

3.7

3.7

Adjusted EBITDA

$      19.5

13.3

13.0

15.7

$      18.1

9.7

8.5

14.9

14.2

Please refer to the “Non-IFRS Financial Measures” & “Non-IFRS Financial Ratios” section of our MD&A for the three-month period ended September 30, 2024 as filed on SEDAR+ for further information regarding Non-IFRS measures.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, including statements concerning possible or assumed future results of Corby’s operations. Forward-looking statements typically are preceded by, followed by or include the words “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans” or similar expressions. These statements are being provided for the purposes of providing information about management’s current expectations and plans and allowing investors and others to get a better understanding of our anticipated financial position, results of operations and operating environment. Readers are cautioned that such information may not be appropriate for other purposes and are not guarantees of future performance. Although Corby believes that the forward-looking information in this press release is based on information, assumptions and beliefs which are current, reasonable and complete, this information is necessarily subject to a number of factors, risks and uncertainties that could cause actual results to differ materially from management’s expectations and plans as set forth in such forward-looking information. For more information on the risks, uncertainties and assumptions that could cause Corby’s actual results to differ from current expectations, refer to the Risks and Risk Management section of our Management’s Discussion and Analysis for the three month period ended September 30, 2024 as well as Corby’s other public filings, available at www.sedar.com and at https://corby.ca/en/investors/. Corby does not undertake to update any forward-looking information, whether written or oral, that may be made from time to time by it or on its behalf, to reflect new information, future events or otherwise, except as is required by applicable securities laws. Accordingly, readers should not place undue reliance on forward-looking statements. All financial results are reported in Canadian dollars.

About Corby Spirit and Wine Limited

Corby Spirit and Wine Limited is a leading Canadian manufacturer, marketer and distributor of spirits and imported wines, and ready-to-drink beverages. Corby’s portfolio of owned-brands includes some of the most renowned brands in Canada, including J.P. Wiser’s®, Lot 40®, and Pike Creek® Canadian whiskies, Lamb’s® rum, Polar Ice® vodka and McGuinness® liqueurs, as well as the Ungava® gin, Cabot Trail® maple-based liqueurs and Chic Choc® spiced rum, Cottage Springs® and Nude® ready-to-drink beverages and Foreign Affair® wines. Through its affiliation with Pernod Ricard S.A., a global leader in the spirits and wine industry, Corby also represents leading international brands such as Absolut® vodka, Chivas Regal®, The Glenlivet® and Ballantine’s® Scotch whiskies, Jameson® Irish whiskey, Beefeater® gin, Malibu® rum, Olmeca Altos® and Código 1530® tequilas, Jefferson’s™ and Rabbit Hole® bourbons, Kahlúa ® liqueur, Mumm® champagne, and Jacob’s Creek®, Wyndham Estate®, Stoneleigh®, Campo Viejo®, and Kenwood® wines. Corby is a publicly traded company based in Toronto, Ontario, and is listed on the Toronto Stock Exchange under the trading symbols CSW.A and CSW.B. For further information, please visit our website or follow us on LinkedIn.

SOURCE Corby Spirit and Wine Limited

Cision View original content: http://www.newswire.ca/en/releases/archive/November2024/13/c6495.html

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Top 4 Tech Stocks That May Keep You Up At Night This Quarter

As of Nov. 13, 2024, four stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.

Here’s the latest list of major overbought players in this sector.

Olo Inc OLO

  • On Nov. 7, Olo posted better-than-expected quarterly earnings. “Team Olo executed well on our top priorities in the third quarter and positioned us to complete a successful 2024. We continued to win, retain, and expand with brands, we drove further innovation across our Order, Pay, and Engage product suites — including the general availability of Olo Pay’s card-present functionality on Qu point-of-sale systems — and we delivered revenue and bottom line performance that exceeded the high-end of our guidance ranges,” said Noah Glass, Olo’s Founder and CEO. The company’s stock gained around 44% over the past month and has a 52-week high of $7.04.
  • RSI Value: 90.08
  • OLO Price Action: Shares of Olo gained 10.6% to close at $6.90 on Tuesday.

Couchbase Inc BASE

  • Couchbase will report financial results for its third quarter ended Oct. 31, on Tuesday, Dec. 3 after market close. The company’s stock gained around 18% over the past month and has a 52-week high </em></a> of $32.00.
  • RSI Value: 78.49
  • BASE Price Action: Shares of Couchbase gained 5.5% to close at $19.57 on Tuesday.

BILL Holdings Inc BILL

  • On Nov. 7, BILL Holdings reported better-than-expected first-quarter financial results and issued FY25 guidance above estimates. The company’s stock jumped around 45% over the past five days and has a 52-week high is $275.52.
  • RSI Value: 90.16
  • BILL Price Action: Shares of BILL gained 3.6% to close at $89.01 on Tuesday.

Zscaler Inc ZS

  • Zscaler will release first quarter fiscal year 2025 earnings after the closing bell on Monday, Dec. 2. The company’s stock jumped around 9% over the past five days and has a 52-week high of $259.58.
  • RSI Value: 76.64
  • ZS Price Action: Shares of Zscaler climbed 4.8% to close at $209.04 on Tuesday.

Read More:

Market News and Data brought to you by Benzinga APIs

Why Is Instacart Parent Maplebear Stock Sliding Today?

Maplebear Inc CART shares are trading lower in premarket Wednesday after the company reported third-quarter financial results.

Revenue of $852.0 million exceeded the consensus of $844.1 million. EPS of 42 cents exceeded the consensus of 22 cents.

Gross transaction value was $8.30 billion in the quarter (+11% year-over-year), and orders came in at 72.9 million, up 10% year-over-year.

Transaction revenue stood at $606 million (+12% year-over-year) and Advertising & other revenue of $246 million (+11% year-over-year).

Gross profit rose 14% year-over-year to $641 million, and adjusted EBITDA surged 39% year-over-year to $227 million in the quarter.

As of September 30, cash and cash equivalents stood at $1.44 billion. As of the third quarter, the company cumulatively repurchased a total of $1.432 billion worth of shares. By September 30, there was $68 million remaining in buyback capacity. Additionally, the company announced a $250 million increase to its buyback program.

Outlook: Maplebear expects a fourth-quarter gross transaction value of $8.50 billion – $8.65 billion and adjusted EBITDA of $230 million – $240 million.

The company noted that the GTV outlook represents year-over-year growth of 8% to 10% even as it compares against last year’s strong holiday season, as it laps a meaningful sequential step up in incentive spend in the prior year quarter, and as it accounts for a small impact from Ahold Delhaize’s recent outage given it powers deliveries for their owned and operated websites.

Price Action: CART shares are down 6.91% at $45.00 premarket at the last check Wednesday.

Image via Shutterstock

Read Next:

Market News and Data brought to you by Benzinga APIs

Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression

Cybin Inc. CYBN has launched its Phase 3 pivotal program called PARADIGM, which is aimed at testing the efficacy of its lead candidate, CYB003, for treating Major Depressive Disorder (MDD) in a move that comes after three years of development.

“Just three years after filing an Investigational New Drug application for CYB003, the initiation of our Phase 3 program is a truly significant and gratifying milestone,” said Doug Drysdale, CEO of Cybin.

The design of the PARADIGM program, according to Drysdale, has been shaped by a collaborative process with the Food and Drug Administration (FDA), taking into account the challenges faced by other companies in this space. He said the trials are recruiting from a broader MDD population, allowing patients to stay on their existing antidepressant regimen while testing CYB003 as an additional treatment.

“The program name, PARADIGM, represents our belief that CYB003 could have the potential for a paradigm shift in the treatment of depression,” the company shared in a press release.

See Also: EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program

Breaking Down The Phase 3 Program

The PARADIGM program consists of three key studies:

  1. APPROACH will enroll 220 participants across 36 sites in the U.S. and Europe. The study compares a 16 mg dose of CYB003 against a placebo, with two doses given three weeks apart. The main goal is to assess the change in depressive symptoms using the MADRS score at the six-week mark.
  2. EMBRACE will involve 330 participants, testing 16 mg and 8 mg doses of CYB003 alongside a placebo. It follows a similar two-dose regimen, focusing on patients whose current antidepressants are not providing adequate relief. This trial spans 48 clinical sites.
  3. EXTEND will roll over participants from the first two studies, offering additional doses of CYB003 to those who do not respond or who relapse. The aim is to evaluate the long-term effects of the treatment.

“Our unique Phase 3 pivotal program design has been informed by the impressive Phase 2 (four-month) data showing rapid, robust improvements in symptoms of depression with a single dose of CYB003, and durable effects four months after two doses with a 75% remission rate in the 16 mg dose group,” explained Amir Inamdar, Cybin’s chief medical officer.

Promising Results From Phase 2

The Phase 2 trial results set the stage for these new studies. Both the 12 mg and 16 mg dosing groups showed a mean reduction of about 22 points in MADRS scores. For the 16 mg group, 75% of patients achieved a response, defined as at least a 50% reduction in MADRS scores and the same percentage reached remission (MADRS score ≤10).

In terms of safety, CYB003 was well tolerated, with only mild or moderate adverse events reported. No serious drug-related adverse events were noted and there were no cases of suicidal ideation or discontinuations due to side effects.

Next Steps And Future Plans

The APPROACH study is already underway, with initial results expected in 2026. EMBRACE is slated to begin in early 2025. Beyond CYB003, Cybin is also progressing with its deuterated DMT program, CYB004, now in Phase 2 trials for generalized anxiety disorder. Results from this study are anticipated in the first quarter of 2025.

“The need for improved treatments for mental health disorders has never been greater,” said Inamdar.

Financial Update: Q2 Fiscal Year 2025

Cybin also reported its financial results for the second quarter ending September 30, 2024:

  • Cash totaled C$154.3 million as of September 30, 2024. With the completion of offerings and assuming the full exercise of issued warrants, the company has access to over C$219.2 million.
  • Cash-based operating expenses, including research, general, and administrative costs, amounted to C$24.8 million, a significant increase from C$12.4 million during the same quarter last year.
  • The company reported a net loss of C$57.2 million for the quarter, compared to a net loss of C$11.9 million in the prior year, which includes a one-time, non-cash expense related to share-based compensation.
  • Cash flows used in operating activities were C$25.9 million, up from C$11.5 million in the same period last year.

Read Next:

Market News and Data brought to you by Benzinga APIs

Sofwave Medical Reports Third Quarter 2024 Financial Results and Business Highlights

— Third quarter revenue of $13.5M, +10.5% year-over-year growth; IFRS gross margin of 75.2%
— Third quarter pulse recurring revenue of $5.4M, +72% year-over-year growth
— First nine months revenue of $41.3M, +18% year-over-year growth; IFRS gross margin of 75.5%
— First nine months IFRS and non-IFRS operating loss decreased 55% and 70%, respectively, to $3.5M vs $7.8M and $1.8M vs $6.0M in the same year ago period
— Generated positive quarterly cash flow

SAN CLEMENTE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd SOFW, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the third quarter and first nine months of fiscal year 2024, for the period ended September 30, 2024, and recent business highlights.

Third Quarter and First Nine Months 2024 Financial Highlights

  • Third Quarter Revenue of $13.5M; representing 10.5% year-over-year growth
    • Recurring revenue of $5.4M, a year-over-year increase of 72%, representing 40% of total revenue
    • Gross Profit was $10.2M, a year-over-year increase of 14%
    • IFRS Gross Margin: 75.2%; *Non-IFRS: 75.3%
    • IFRS Operating Loss: $1.3M; *Non-IFRS: $0.8M
    • Cash from Operating Activities: $0.2M compared to $1M of cash used in the corresponding period
  • First Nine Months Revenue of $41.3M, representing 18% year-over-year growth
    • Recurring revenue of $16.1M, a year-over-year increase of 88%, representing 39% of total revenue
    • Gross Profit was $31.2M, a year-over-year increase of 21%
    • IFRS Gross Margin: 75.5%; *Non-IFRS: 75.7%
    • IFRS Operating Loss: $3.5M; down from $7.8M during first nine months of 2023; *Non-IFRS: $1.8M
  • Cash and Cash Equivalents as of September 30, 2024: $21.2M

Management Commentary

Mr. Louis Scafuri, Sofwave CEO, commented, “Sofwave continues to deliver and expand its industry leading non-invasive medical aesthetic product portfolio to customers and patients. Moreover, in the face of both challenging macro-economic and medical aesthetic market pressures, we continue to generate strong top- and bottom-line results. During the first nine months of 2024, the Company experienced significant double-digit revenue and gross profit growth, and an increase of recurring pulse sales representing nearly 40% of total revenue, while substantially narrowing operating loss. We believe this is a result of not only Sofwave’s superior business model, which enables faster ROI, and rapidly expanding brand awareness, but also the delivery of best-in-class patient results, which is driving further repeat business.”

Dr. Shimon Eckhouse, Chairman & Co-Founder, added, “Since the commercial launch of Sofwave in 2020, over 385,000 treatments have been conducted with our transformative technology. We have nine FDA clearances and the emergence of GLP-1 agonists that are driving demand for tightening, lifting, laxity improvement and toning is providing us the opportunity to fully leverage these broad regulatory approvals. Looking ahead, we have a scalable, lean infrastructure that will support continued top-line growth and bottom-line improvement.”

Recent Operational Highlights

  • Dr. Kavita Darji wins the Drs. Alastair and Jean D. Carruthers Award at ASDS 2024 for Sofwave SUPERB™ abstract
  • Larry Laber, aesthetic energy-based device sales leadership veteran, joins Sofwave as Executive Vice President, North American Sales
  • Over 385,000 treatments conducted since initial market approval
  • Sofwave appoints Mr. Miguel Pardos to the role of Chief Commercial Officer

Mr. Miguel Pardos is a seasoned C-Suite executive with over 25 years of experience in the international medical aesthetics and healthcare industry. He has a strong track record as an industry leader in addition to successfully accelerating revenue growth at companies while under his helm. Before joining Sofwave, Mr. Pardos served as the Chief Executive Officer of Sinclair, a UK-based aesthetic company with a portfolio of injectables and energy-based devices. Previously held positions include CEO of Cocoon Medical, EVP International at Cutera, VP of APAC at Syneron Candela and various leadership positions at GE Healthcare. Mr. Pardos holds a BSc in Engineering and an MBA from Instituto de Empresa (Ie).

Financial Summary

IFRS Results
(U.S. dollars in thousands)
  Q324 Q323 9M’24 9M’23
Revenues $13,507 $12,226 $41,333 $35,013
Gross Profit $10,156 $8,920 $31,218 $25,830
Gross Margin 75.2% 73.0% 75.5% 73.8%
Operating Loss ($1,314) ($1,210) ($3,484) ($7,826)
*Non-IFRS Results
(U.S. dollars in thousands)
  Q324 Q323 9M’24 9M’23
Revenues $13,507 $12,226 $41,333 $35,013
Gross Profit $10,170 $8,952 $31,271 $25,946
Gross Margin 75.3% 73.2% 75.7% 74.1%
Operating Loss ($785) ($726) ($1,785) ($5,967)

(*) Excluding stock-based compensation

About Sofwave Medical Ltd.

Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), to improve the appearance of skin laxity on the upper arms, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars. The company’s Pure Impact™ module uses EMS technology and is cleared for muscle toning. Sofwave’s products provide physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: Info@sofwave.com

Contact: Info@sofwave.com

Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
britchie@lifesciadvisors.com


Primary Logo

Market News and Data brought to you by Benzinga APIs

Chipotle Rival CAVA Surges Over 17% As Q3 Earnings Beat Expectations And Full-Year Outlook Improves

CAVA Group Inc. CAVA experienced a significant stock price increase of 17.18% during pre-market on Wednesday after announcing robust third-quarter earnings and revising its annual outlook upwards, according to Benzinga Pro.

The fast-casual chain, known for its Mediterranean-inspired cuisine, reported earnings of 15 cents per share, surpassing the analyst consensus of 11 cents. Quarterly revenue reached $243.82 million, exceeding expectations of $233.59 million and marking an increase from $175.55 million in the same period last year.

The company, a rival to Chipotle Mexican Grill, Inc. CMG opened 11 new restaurants, bringing the total to 352, reflecting a 21.4% year-over-year growth in restaurant count.

See Also: Dogecoin Swells 29%, Becomes Sixth-Largest Crypto As Investors Await Elon Musk-Headed DOGE Department Under Trump

Same-restaurant sales grew by 18.1%, with guest traffic up by 12.9%. The average unit volume (AUV) was reported at $2.8 million, compared to $2.6 million in the previous year. Restaurant-level profit rose by 41.9% to $61.8 million, with a profit margin of 25.6%.

CEO Brett Schulman highlighted the brand’s strength and strategic initiatives, including a new loyalty program and labor model. The company increased its fiscal year 2024 outlook for new restaurant openings and same-restaurant sales growth. CAVA shares rose 14.80% after-hours, trading at $166.

Read Next:

Photo via Shutterstock

This story was generated using Benzinga Neuro and edited by Pooja Rajkumari

Market News and Data brought to you by Benzinga APIs

Dogecoin Tumbles Despite Elon Musk, Vivek Ramaswamy's 'DOGE' Appointment: This Is What Indicators Tell About Its Next Moves

Following weeks of relentless promotion, the Department of Government Efficiency (DOGE) is set to become a reality, potentially sending the price of Dogecoin DOGE/USD to unprecedented levels.

What happened: On Tuesday, President-elect Donald Trump appointed Elon Musk, the conceiver of the idea, and entrepreneur-turned-politician Vivek Ramaswamy to oversee the department, which aims to streamline federal bureaucracy and eliminate “excess” laws.

The duo immediately acknowledged the appointment and began divulging details about the incoming department.

Musk announced that all DOGE’s actions could be tracked online for “maximum” transparency.

“Anytime the public thinks we are cutting something important or not cutting something wasteful, just let us know,” the tech mogul added.

Ramaswamy stated that DOGE would begin crowdsourcing examples of government waste and fraud, aiming to make the average American a partner in bringing about the desired reforms.

See Also: Shiba Inu Lead Developer Shytoshi Kusama Pitches S.H.I.B In Response To Elon Musk’s Call For New Roles Recommendations In Trump Administration

Effect on DOGE: As counter-intuitive as it may sound, the meme cryptocurrency DOGE tumbled 8.30% in the last 24 hours, dipping below 40 cents.

Investors seem to be profiting from the gains made in the weeklong rally that pushed the coin to as high as 43 cents, which is a gain of nearly 94% in this period.

DOGE’s Relative Strength Index (RSI) was in the overbought zone as of this writing, as tracked by TradingView, indicating the possibility of a correction.

The number of short positions taken for the meme coin rose vis à vis longs, according to Coinglass, lending credence to the above observation.

Having said that, more DOGE was withdrawn from exchanges than deposited in the last 24 hours, according to IntoTheBlock, indicating that the HODLing sentiment was still strong.

Price Action: At the time of writing, DOGE was exchanging hands at $0.3831 down 8.30% in the last 24 hours, according to data from Benzinga Pro

Read Next: 

Photo courtesy: Flickr

Market News and Data brought to you by Benzinga APIs

NETSOL Technologies Reports 3% Total Net Revenue Growth With 26% Increase in Recurring Revenue and Net Profitability in Fiscal First Quarter 2025

  • 3% increase in 1Q’25 total net revenues to $14.6 million
  • 26% increase in 1Q’25 subscription and support revenues to $8.2 million
  • 45% gross margins in 1Q’25
  • Net income in 1Q’25 of $71,000 building on FY’24 profitability
  • Cash and cash equivalents increased to $24.5 million
  • Signed expansion agreement with major automaker in China increasing contract value to over $30 million
  • Signed $16 million agreement with major automaker in the United States

ENCINO, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and asset finance solutions provider, reported results for the fiscal first quarter of 2025 ended September 30, 2024.

Najeeb Ghauri, Co-Founder, Chief Executive Officer, and Chairman of NETSOL Technologies Inc., commented, “We’re continue to build on the foundation we laid in 2024, achieving profitability in the first fiscal quarter of 2025 driven by a 26% increase in recurring subscription and support revenues and consistent services revenues when compared to the first quarter of fiscal 2024. Moreover, we are strengthening our balance sheet and are aggressively but strategically investing in the growth of our business, with a particular focus on AI, as we expand our product offerings and grow our presence in both new and existing geographic markets.”

Fiscal First Quarter 2025 Financial Results

Total net revenues for the first quarter of fiscal 2025 increased 3% to $14.6 million, compared with $14.2 million in the prior year period, driven by a 26% increase in subscription and support revenues and consistent services revenues in the quarter. On a constant currency basis, total net revenues were $14.5 million.

  • No meaningful license fees compared with $1.3 million in the prior year period.
  • Total subscription (SaaS and Cloud) and support revenues increased 26% to $8.2 million compared with $6.5 million in the prior year period. Total subscription and support revenues as percentage of sales increased to 56%, compared with 46% in the prior year period. Total subscription and support revenues on a constant currency basis were $8.1 million.
  • Total services revenues were $6.4 million, compared with $6.5 million in the prior year period. Total services revenues on a constant currency basis were $6.3 million.

Gross profit for the first quarter of fiscal 2025 was $6.6 million or 45% of net revenues, compared to $6.2 million or 43% of net revenues in the first quarter of fiscal 2024. On a constant currency basis, gross profit was $6.7 million or 46% of net revenues as measured on a constant currency basis.

Operating expenses for the first quarter of fiscal 2025 were $7.3 million or 50% of sales compared to $5.8 million or 41% of sales for the first quarter of fiscal 2024. On a constant currency basis, operating expenses were $7.2 million or 49% of sales on a constant currency basis.

Loss from operations for the first quarter of fiscal 2025 was $(760,000) compared to income from operations of $350,000 in the first quarter of fiscal 2024.

GAAP net income attributable to NETSOL for the first quarter of fiscal 2025 totaled $71,000 or $0.006 per diluted share, compared with GAAP net income of $31,000 or 0.003 per diluted share in the prior year period.

Non-GAAP EBITDA for the first quarter of fiscal 2025 was $302,000 or $0.03 per diluted share, compared with non-GAAP EBITDA of $805,000 or $0.07 per diluted share in the first quarter of fiscal 2024 (see note regarding “Use of Non-GAAP Financial Measures,” below for further discussion of this non-GAAP measure).

Non-GAAP adjusted EBITDA for the first quarter of fiscal 2025 was $204,000 or $0.02 per diluted share, compared with a non-GAAP adjusted EBITDA of $466,000 or $0.04 per diluted share in the prior year period (see note regarding “Use of Non-GAAP Financial Measures,” below for further discussion of this non-GAAP measure).

Balance Sheet and Capital Structure

Cash and cash equivalents was $24.5 million as of September 30, 2024, compared with $19.1 million as of June 30, 2024. Working capital was $24.2 million as of September 30, 2024, compared with $23.6 million as of June 30, 2024. Total NETSOL stockholders’ equity at September 30, 2024, was $34.7 million or $3.03 per share.

Management Commentary

“Our performance in the first quarter of 2025 was driven by encouraging trends including a double-digit increase in subscription and support revenue and consistent services revenues when compared to the first quarter of 2024,” Najeeb Ghauri, Co-Founder, Chief Executive Officer, and Chairman of NETSOL Technologies Inc., commented. “Importantly, we achieved these results without recognizing any meaningful license fees in the quarter, demonstrating a shift in our revenue to rely less on large, one-time licensing fees and benefit from more predictable and consistent SaaS sales.

“We continued to invest in the growth of our business during the quarter,” Mr. Ghauri continued. “Geographic expansion remains a key strategic focus for us, and we believe that there is significant opportunity for growth in new markets, as well as the ones that we currently hold a leadership position in as we continue to innovate and evolve our product offerings to meet shifting market demands. The recent product rebranding has been particularly well received and we’re focused on investing in our business development initiatives to create a more sustainable pipeline of opportunities across all our markets.

“Growth in the United States continues to be a top priority, and we’re making encouraging progress as we continue to penetrate this region. During the quarter, we announced a five-year, $16 million deal with a major automaker and to revolutionize their digital car buying experience through Transcend Retail, our omnichannel digital retail platform. We’re performing in our established markets as well – during the quarter, we signed an expansion agreement with a major automaker in China increasing the contract value to over $30 million, demonstrating our strength of customer relationships and ongoing demand for our products from Tier 1 names in the auto industry. We remain confident that we will be able to achieve double digit revenue growth this fiscal year.”

Roger Almond, Chief Financial Officer of NETSOL Technologies Inc., commented, “Our first quarter results reflect the strengthening of our business model with solid growth of our recurring revenue base. From a liquidity standpoint, we strengthened our balance sheet in the quarter with a cash position of $24.5 million compared with $19.1 million at the close of fiscal 2024, as well as improved working capital. Looking ahead, we believe that NETSOL is well positioned to deliver double-digit revenue growth in fiscal 2025 and drive enhanced value for our shareholders.”

Conference Call

NETSOL Technologies management will hold a conference call on Wednesday, November 13, at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time) to discuss these financial results. A question-and-answer session will follow management’s presentation.

U.S. dial-in: 877-407-0789
International dial-in: 201-689-8562

Please call the conference telephone number 5-10 minutes prior to the start time and provide the operator with the conference ID: NETSOL. The operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Investor Relations at 203-972-9200.

The conference call will also be broadcast live and available for replay here, along with additional replay access being provided through the company information section of NETSOL’s website.

A telephone replay of the conference call will be available approximately three hours after the call concludes through Wednesday, November 27, 2024.

Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay ID: 13750042

About NETSOL Technologies
NETSOL Technologies, Inc. NTWK is a worldwide provider of IT and enterprise software solutions primarily serving the global leasing and finance industry. The Company’s suite of applications is backed by 40 years of domain expertise and supported by a committed team of professionals placed in ten strategically located support and delivery centers throughout the world. NETSOL’s products help companies transform their finance and leasing operations, providing a fully automated asset-based finance solution covering the complete leasing and finance lifecycle.

Forward-Looking Statements
This press release may contain forward-looking statements relating to the development of the Company’s products and services and future operation results, including statements regarding the Company that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. The words “expects,” “anticipates,” variations of such words, and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Factors that could affect the Company’s actual results include the progress and costs of the development of products and services and the timing of the market acceptance. The subject Companies expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.

Use of Non-GAAP Financial Measures
The reconciliation of Adjusted EBITDA to net income, the most comparable financial measure based upon GAAP, as well as a further explanation of adjusted EBITDA, is included in the financial tables in Schedule 4 of this press release.

Investor Relations Contact:

IMS Investor Relations
netsol@imsinvestorrelations.com
+1 203-972-9200

       
NETSOL Technologies, Inc. and Subsidiaries
Schedule 1: Consolidated Balance Sheets
       
  As of   As of
ASSETS September 30, 2024   June 30, 2024
Current assets:      
Cash and cash equivalents $ 24,525,956     $ 19,127,165  
Accounts receivable, net of allowance of $15,533 and $398,809   5,936,063       13,049,614  
Revenues in excess of billings, net of allowance of $460,743 and $116,148   12,743,571       12,684,518  
Other current assets   3,328,112       2,600,786  
Total current assets   46,533,702       47,462,083  
Revenues in excess of billings, net – long term   866,388       954,029  
Property and equipment, net   4,847,869       5,106,842  
Right of use assets – operating leases   1,216,835       1,328,624  
Other assets   32,341       32,340  
Intangible assets, net          
Goodwill   9,302,524       9,302,524  
Total assets $ 62,799,659     $ 64,186,442  
       
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable and accrued expenses $ 8,414,790     $ 8,232,342  
Current portion of loans and obligations under finance leases   6,443,937       6,276,125  
Current portion of operating lease obligations   590,541       608,202  
Unearned revenue   6,923,112       8,752,153  
Total current liabilities   22,372,380       23,868,822  
Loans and obligations under finance leases; less current maturities   92,638       95,771  
Operating lease obligations; less current maturities   594,631       688,749  
Total liabilities   23,059,649       24,653,342  
       
Stockholders’ equity:      
Preferred stock, $.01 par value; 500,000 shares authorized;          
Common stock, $.01 par value; 14,500,000 shares authorized;      
12,383,872 shares issued and 11,444,841 outstanding as of September 30, 2024 ,      
12,359,922 shares issued and 11,420,891 outstanding as of June 30, 2024   123,842       123,602  
Additional paid-in-capital   128,709,890       128,783,865  
Treasury stock (at cost, 939,031 shares      
as of September 30, 2024 and June 30, 2024)   (3,920,856 )     (3,920,856 )
Accumulated deficit   (44,141,518 )     (44,212,313 )
Other comprehensive loss   (46,049,023 )     (45,935,616 )
Total NetSol stockholders’ equity   34,722,335       34,838,682  
Non-controlling interest   5,017,675       4,694,418  
Total stockholders’ equity   39,740,010       39,533,100  
Total liabilities and stockholders’ equity $ 62,799,659     $ 64,186,442  
               
NETSOL Technologies, Inc. and Subsidiaries
Schedule 2: Consolidated Statement of Operations
   
  For the Three Months
  Ended September 30,
  2024   2023
Net Revenues:      
License fees $ 1,229     $ 1,280,449  
Subscription and support   8,192,471       6,512,243  
Services   6,404,798       6,449,489  
Total net revenues   14,598,498       14,242,181  
       
Cost of revenues   8,034,386       8,080,164  
Gross profit   6,564,112       6,162,017  
       
Operating expenses:      
Selling, general and administrative   6,964,321       5,432,969  
Research and development cost   359,949       378,419  
Total operating expenses   7,324,270       5,811,388  
       
Income (loss) from operations   (760,158 )     350,629  
       
Other income and (expenses)      
Interest expense   (258,219 )     (276,017 )
Interest income   769,867       414,718  
Gain (loss) on foreign currency exchange transactions   542,545       (134,253 )
Other income   153,491       57,881  
Total other income (expenses)   1,207,684       62,329  
       
Net income before income taxes   447,526       412,958  
Income tax provision   (229,817 )     (121,895 )
Net income   217,709       291,063  
Non-controlling interest   (146,914 )     (260,173 )
Net income attributable to NetSol $ 70,795     $ 30,890  
       
       
Net income per share:      
Net income per common share      
Basic $ 0.006     $ 0.003  
Diluted $ 0.006     $ 0.003  
       
Weighted average number of shares outstanding      
Basic   11,429,695       11,345,856  
Diluted   11,482,754       11,345,856  
               
NETSOL Technologies, Inc. and Subsidiaries
Schedule 3: Consolidated Statement of Cash Flows
   
  For the Three Months
  Ended September 30,
  2024   2023
Cash flows from operating activities:      
Net income $ 217,709     $ 291,063  
Adjustments to reconcile net income to net cash      
provided by operating activities:      
Depreciation and amortization   365,997       530,786  
Provision (reversal) for bad debts   336,506       7,880  
(Gain) loss on sale of assets         (98 )
Stock based compensation   47,779       60,354  
Changes in operating assets and liabilities:      
Accounts receivable   6,738,384       4,608,881  
Revenues in excess of billing   836,403       (1,478,386 )
Other current assets   (222,359 )     92,686  
Accounts payable and accrued expenses   10,546       341,722  
Unearned revenue   (2,813,220 )     (2,791,269 )
Net cash provided by operating activities   5,517,745       1,663,619  
       
Cash flows from investing activities:      
Purchases of property and equipment   (100,737 )     (371,630 )
Sales of property and equipment         1,230  
Purchase of subsidiary shares   (7,895 )      
Net cash used in investing activities   (108,632 )     (370,400 )
       
Cash flows from financing activities:      
Proceeds from the exercise of stock options   21,500        
Proceeds from bank loans   250,000        
Payments on finance lease obligations and loans – net   (118,311 )     (44,474 )
Net cash provided by (used in) financing activities   153,189       (44,474 )
Effect of exchange rate changes   (163,511 )     (230,322 )
Net increase (decrease) in cash and cash equivalents   5,398,791       1,018,423  
Cash and cash equivalents at beginning of the period   19,127,165       15,533,254  
Cash and cash equivalents at end of period $ 24,525,956     $ 16,551,677  
               
NETSOL Technologies, Inc. and Subsidiaries
Schedule 4: Reconciliation to GAAP
   
  For the Three Months
  Ended September 30,
  2024   2023
       
Net Income (loss) attributable to NetSol $ 70,795     $ 30,890  
Non-controlling interest   146,914       260,173  
Income taxes   229,817       121,895  
Depreciation and amortization   365,997       530,786  
Interest expense   258,219       276,017  
Interest (income)   (769,867 )     (414,718 )
EBITDA $ 301,875     $ 805,043  
Add back:      
Non-cash stock-based compensation   47,779       60,354  
Adjusted EBITDA, gross $ 349,654     $ 865,397  
Less non-controlling interest (a)   (145,781 )     (399,440 )
Adjusted EBITDA, net $ 203,873     $ 465,957  
       
Weighted Average number of shares outstanding      
Basic   11,429,695       11,345,856  
Diluted   11,482,754       11,345,856  
       
Basic adjusted EBITDA $ 0.02     $ 0.04  
Diluted adjusted EBITDA $ 0.02     $ 0.04  
       
       
(a)The reconciliation of adjusted EBITDA of non-controlling interest      
to net income attributable to non-controlling interest is as follows      
       
Net Income (loss) attributable to non-controlling interest $ 146,914     $ 260,173  
Income Taxes   70,587       36,377  
Depreciation and amortization   89,135       141,351  
Interest expense   79,192       85,889  
Interest (income)   (242,647 )     (128,091 )
EBITDA $ 143,181     $ 395,699  
Add back:      
Non-cash stock-based compensation   2,600       3,741  
Adjusted EBITDA of non-controlling interest $ 145,781     $ 399,440  
               


Primary Logo

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.